首页   按字顺浏览 期刊浏览 卷期浏览 Intratympanic Dexamethasone for Sudden Sensorineural Hearing Loss: Clinical and L...
Intratympanic Dexamethasone for Sudden Sensorineural Hearing Loss: Clinical and Laboratory Evaluation

 

作者: Sujana Chandrasekhar,  

 

期刊: Otology & Neurotology  (OVID Available online 2001)
卷期: Volume 22, issue 1  

页码: 18-23

 

ISSN:1531-7129

 

年代: 2001

 

出版商: OVID

 

关键词: Dexamethasone;Sudden sensorineural hearing loss

 

数据来源: OVID

 

摘要:

ObjectiveTo discuss the value of intratympanic dexamethasone (IT-DEX) perfusion for sudden sensorineural hearing loss (SSNHL), clinically and in an animal model.Study DesignRetrospective case review of 10 patients with SSNHL treated with IT-DEX. The findings are correlated with this institution's previous findings from a study of IT-DEX in guinea pigs.SettingAmbulatory tertiary otologic referral center.PatientsSequential patients with SSNHL who chose IT-DEX treatment.InterventionsDexamethasone 0.5 mg was injected transtympanically and bathed the round window for 20 minutes. Animal study: 79 ears were randomized into five groups: control, IT-DEX versus intravenous (IV)-DEX, IT-DEX with histamine, IT-DEX with hyaluronic acid, and IT-DEX with dimethylsulfoxide.Main Outcome MeasuresClinical study: postprocedure audiometry. Animal study: perilymph steroid concentration.ResultsIT-DEX results in significant hearing improvement and in significantly higher perilymph concentration of steroid than IV-DEX.ConclusionsIT-DEX is an appropriate treatment option for the treatment of SSNHL. Further study of dosages and frequency of administration is warranted.

 

点击下载:  PDF (136KB)



返 回